Hemovent Overview
- Founded
-
2013

- Status
-
Acquired/Merged
- Employees
-
20

- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$143M
Hemovent General Information
Description
Developer of a medical device designed to support or replace heart and lung functions in the event of cardiac or respiratory failure. The company's device provides respiratory support to patients whose lungs are so damaged that they cannot perform their basic functions and acts as a temporary life support system by taking over the hearts function in case of an acute heart failure, thus providing hospitals with enough time to address the underlying problems that caused the failure.
Contact Information
Website
www.hemovent.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Parent Company
Primary Office
- Pascalstraße 59
- 52076 Aachen
- Germany
+49 0241 0000000
Hemovent Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
6. Merger/Acquisition | 13-Oct-2021 | $143M | 000.00 | 00000 | Completed | Generating Revenue |
5. Later Stage VC (Series B) | 07-Jul-2020 | 000.00 | 000.00 | 000.00 | Completed | Generating Revenue |
4. Accelerator/Incubator | 01-Jan-2019 | 000.00 | Completed | Generating Revenue | ||
3. Early Stage VC (Series A) | 25-Jul-2017 | 00.00 | 000.00 | 000.00 | Completed | Generating Revenue |
2. Grant | 24-Apr-2017 | $810K | $6M | Completed | Generating Revenue | |
1. Early Stage VC (Series A) | 10-Feb-2016 | $6M | $6M | 000.00 | Completed | Generating Revenue |
Hemovent Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of a medical device designed to support or replace heart and lung functions in the event of cardiac or respira
Therapeutic Devices
Aachen, Germany
20
As of 2021
000.00
0000
0000-00-00
000000&0
000.00
Hemovent Competitors (8)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Abiomed | Corporation | Danvers, MA | 0000 | 000.00 | 000000&0 | 000.00 |
00000000 | Formerly VC-backed | London, United Kingdom | 0000 | 000.00 | 000000000000 | |
000000 | Formerly VC-backed | Heilbronn, Germany | 000 | 000000&0 | ||
00000000 | Corporation | Medolla, Italy | 000 | |||
000000 | Corporation | Tokyo, Japan | 00000 | 00000000 |
Hemovent Patents
Hemovent Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
DE-112020003267-A5 | Blood test device | Pending | 09-Jul-2019 | 000000000 | |
EP-3997442-A1 | Blood testing device | Pending | 09-Jul-2019 | 000000000 | |
US-20220355003-A1 | Blood testing device | Pending | 09-Jul-2019 | 000000000 | |
DE-112019000979-A5 | Holding device for holding an oxygenator and a blood pump | Pending | 26-Feb-2018 | 0000000000 | |
EP-3758769-A1 | Holding device for holding an oxygenator and a blood pump | Pending | 26-Feb-2018 | A61M1/1652 |
Hemovent Executive Team (2)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Christof Lenz | Co-Founder & Chief Executive Officer | ||
Oliver Marseille Ph.D | Co-Founder, Chief Technology Officer & Entrepreneur |
Hemovent Signals
Hemovent Former Investors (11)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
First Capital Partner | Venture Capital | Minority | 000 0000 | 000000 0 | |
German Accelerator | Accelerator/Incubator | 000 0000 | 000000 0 | ||
Government of Germany | Government | 000 0000 | 000000 0 | ||
KfW Group | Investment Bank | Minority | 000 0000 | 000000 0 | |
MIG AG | Venture Capital | Minority | 000 0000 | 000000 0 |